XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Previously Reported
Revision of Prior Period, Reclassification, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Reclassification, Adjustment
Treasury Stock
Treasury Stock
Previously Reported
Treasury Stock
Revision of Prior Period, Reclassification, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Reclassification, Adjustment
Accumulated Deficit
Accumulated Deficit
Previously Reported
Convertible Redeemable Preferred stock, beginning balance (in shares) at Mar. 31, 2021 7,752,515 7,752,515                        
Convertible Redeemable Preferred Stock, beginning balance at Mar. 31, 2021 $ 59,987 $ 59,987                        
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Conversion of Preferred Shares (in shares) (7,752,515)                          
Conversion of Preferred Shares $ (59,987)                          
Convertible Redeemable Preferred Stock, ending balance (in shares) at Jun. 30, 2021 0                          
Convertible Redeemable Preferred Stock, ending balance at Jun. 30, 2021 $ 0                          
Shares outstanding, beginning balance (in shares) at Mar. 31, 2021       48,071,777 5,498,588 42,573,189 0 259,953 (259,953)          
Beginning balance at Mar. 31, 2021 (158,970) $ (158,970) $ 0 $ 0 $ 0   $ 0 $ (4,764) $ 4,764 $ 20,984 $ 25,748 $ (4,764) $ (179,954) $ (179,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (24,804)                       (24,804)  
Issuance for stock options exercised (in shares)       424,384                    
Issuance for stock options exercised 197                 197        
Issuance for warrants exercised (in shares)       231,153                    
Issuance for warrants exercised 104                 104        
Stock-based compensation 3,098                 3,098        
Conversion of Preferred Stock (in shares)       7,752,515                    
Conversion of Preferred Shares 59,987                 59,987        
Conversion of Convertible Notes (in shares)       1,135,713                    
Conversion of Convertible Notes 11,976                 11,976        
PIPE Issuance (in shares)       20,000,000                    
PIPE Issuance 200,000                 200,000        
Net equity infusion from the Merger (in shares)       89,088,942                    
Net equity infusion from the Merger 150,257     $ 1           150,256        
Cumulative translation adjustment 2                       2  
Shares outstanding, ending balance (in shares) at Jun. 30, 2021       166,704,484     0              
Ending balance at Jun. 30, 2021 241,847     $ 1     $ 0     446,602     (204,756)  
Shares outstanding, beginning balance (in shares) at Mar. 31, 2022       175,290,143                    
Beginning balance at Mar. 31, 2022 217,061     $ 1           465,313     (248,253)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (15,408)                       (15,408)  
Issuance for stock options exercised (in shares)       702,176                    
Issuance for stock options exercised 154                 154        
Issuance for restricted stock units vested (in shares)       106,399                    
Issuance for restricted stock units vested 0                          
Stock-based compensation 4,343                 4,343        
Cumulative translation adjustment 5                       5  
Shares outstanding, ending balance (in shares) at Jun. 30, 2022       176,098,718                    
Ending balance at Jun. 30, 2022 $ 206,155     $ 1           $ 469,810     $ (263,656)